Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASET: Prasugrel monotherapy after PCI
NCT03469856Unknown
- Start
- Feb 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prasugrel in angina pectoris. Primary endpoints: Composite of cardiac death, spontaneous myocardial infarction, or definite stent thrombosis at 3 months and BARC type 3 or 5 bleeding at 3 months. Status: unknown.
02
Drugs
prasugrel
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT03469856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03469856.